The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia

Alessandro Bertolino, Alan Breier, Joseph H. Callicott, Caleb Adler, Venkata Mattay, Maxim Shapiro, Joseph A. Frank, David Pickar, Daniel Weinberger

Research output: Contribution to journalArticle

Abstract

Schizophrenia has been linked to abnormal dopamine function, recently to excessive amphetamine-induced release of striatal dopamine, and also to pathology of prefrontal cortical neurons. It has been hypothesized that prefrontal pathology is a primary condition that leads to dopamine dysregulation. We evaluated in vivo the relationship between neuronal integrity in dorsolateral prefrontal cortex, assessed as N-acetylaspartate (NAA) relative concentrations measured with proton magnetic resonance spectroscopic imaging, and amphetamine-induced release of striatal dopamine, assessed with 11C-raclopride Positron Emission Tomography (PET) in patients with schizophrenia and in healthy subjects. In the patients, NAA measures in dorsolateral prefrontal cortex selectively predicted striatal displacement of 11C-raclopride after amphetamine infusions (rho = - 0.76, p <.02). In contrast, NAA measures in other cortical regions and in healthy subjects did not show any correlation. These results support the hypothesis that in schizophrenia neuronal pathology of dorsolateral prefrontal cortex is directly related to abnormal subcortical dopamine function. Copyright (C) 2000 American College of Neuropsychopharmacology.

Original languageEnglish (US)
Pages (from-to)125-132
Number of pages8
JournalNeuropsychopharmacology
Volume22
Issue number2
DOIs
StatePublished - Feb 2000
Externally publishedYes

Fingerprint

Corpus Striatum
Dopamine
Schizophrenia
Amphetamine
Prefrontal Cortex
Raclopride
Pathology
Healthy Volunteers
Positron-Emission Tomography
Protons
Magnetic Resonance Imaging
N-acetylaspartate
Neurons

Keywords

  • Dopamine
  • Dorsolateral prefrontal cortex
  • Evoked release
  • N-acetylaspartate
  • Schizophrenia
  • Striatum

ASJC Scopus subject areas

  • Pharmacology

Cite this

The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. / Bertolino, Alessandro; Breier, Alan; Callicott, Joseph H.; Adler, Caleb; Mattay, Venkata; Shapiro, Maxim; Frank, Joseph A.; Pickar, David; Weinberger, Daniel.

In: Neuropsychopharmacology, Vol. 22, No. 2, 02.2000, p. 125-132.

Research output: Contribution to journalArticle

Bertolino, Alessandro ; Breier, Alan ; Callicott, Joseph H. ; Adler, Caleb ; Mattay, Venkata ; Shapiro, Maxim ; Frank, Joseph A. ; Pickar, David ; Weinberger, Daniel. / The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. In: Neuropsychopharmacology. 2000 ; Vol. 22, No. 2. pp. 125-132.
@article{18eee42bcfcc412796b0fb971949949c,
title = "The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia",
abstract = "Schizophrenia has been linked to abnormal dopamine function, recently to excessive amphetamine-induced release of striatal dopamine, and also to pathology of prefrontal cortical neurons. It has been hypothesized that prefrontal pathology is a primary condition that leads to dopamine dysregulation. We evaluated in vivo the relationship between neuronal integrity in dorsolateral prefrontal cortex, assessed as N-acetylaspartate (NAA) relative concentrations measured with proton magnetic resonance spectroscopic imaging, and amphetamine-induced release of striatal dopamine, assessed with 11C-raclopride Positron Emission Tomography (PET) in patients with schizophrenia and in healthy subjects. In the patients, NAA measures in dorsolateral prefrontal cortex selectively predicted striatal displacement of 11C-raclopride after amphetamine infusions (rho = - 0.76, p <.02). In contrast, NAA measures in other cortical regions and in healthy subjects did not show any correlation. These results support the hypothesis that in schizophrenia neuronal pathology of dorsolateral prefrontal cortex is directly related to abnormal subcortical dopamine function. Copyright (C) 2000 American College of Neuropsychopharmacology.",
keywords = "Dopamine, Dorsolateral prefrontal cortex, Evoked release, N-acetylaspartate, Schizophrenia, Striatum",
author = "Alessandro Bertolino and Alan Breier and Callicott, {Joseph H.} and Caleb Adler and Venkata Mattay and Maxim Shapiro and Frank, {Joseph A.} and David Pickar and Daniel Weinberger",
year = "2000",
month = "2",
doi = "10.1016/S0893-133X(99)00096-2",
language = "English (US)",
volume = "22",
pages = "125--132",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia

AU - Bertolino, Alessandro

AU - Breier, Alan

AU - Callicott, Joseph H.

AU - Adler, Caleb

AU - Mattay, Venkata

AU - Shapiro, Maxim

AU - Frank, Joseph A.

AU - Pickar, David

AU - Weinberger, Daniel

PY - 2000/2

Y1 - 2000/2

N2 - Schizophrenia has been linked to abnormal dopamine function, recently to excessive amphetamine-induced release of striatal dopamine, and also to pathology of prefrontal cortical neurons. It has been hypothesized that prefrontal pathology is a primary condition that leads to dopamine dysregulation. We evaluated in vivo the relationship between neuronal integrity in dorsolateral prefrontal cortex, assessed as N-acetylaspartate (NAA) relative concentrations measured with proton magnetic resonance spectroscopic imaging, and amphetamine-induced release of striatal dopamine, assessed with 11C-raclopride Positron Emission Tomography (PET) in patients with schizophrenia and in healthy subjects. In the patients, NAA measures in dorsolateral prefrontal cortex selectively predicted striatal displacement of 11C-raclopride after amphetamine infusions (rho = - 0.76, p <.02). In contrast, NAA measures in other cortical regions and in healthy subjects did not show any correlation. These results support the hypothesis that in schizophrenia neuronal pathology of dorsolateral prefrontal cortex is directly related to abnormal subcortical dopamine function. Copyright (C) 2000 American College of Neuropsychopharmacology.

AB - Schizophrenia has been linked to abnormal dopamine function, recently to excessive amphetamine-induced release of striatal dopamine, and also to pathology of prefrontal cortical neurons. It has been hypothesized that prefrontal pathology is a primary condition that leads to dopamine dysregulation. We evaluated in vivo the relationship between neuronal integrity in dorsolateral prefrontal cortex, assessed as N-acetylaspartate (NAA) relative concentrations measured with proton magnetic resonance spectroscopic imaging, and amphetamine-induced release of striatal dopamine, assessed with 11C-raclopride Positron Emission Tomography (PET) in patients with schizophrenia and in healthy subjects. In the patients, NAA measures in dorsolateral prefrontal cortex selectively predicted striatal displacement of 11C-raclopride after amphetamine infusions (rho = - 0.76, p <.02). In contrast, NAA measures in other cortical regions and in healthy subjects did not show any correlation. These results support the hypothesis that in schizophrenia neuronal pathology of dorsolateral prefrontal cortex is directly related to abnormal subcortical dopamine function. Copyright (C) 2000 American College of Neuropsychopharmacology.

KW - Dopamine

KW - Dorsolateral prefrontal cortex

KW - Evoked release

KW - N-acetylaspartate

KW - Schizophrenia

KW - Striatum

UR - http://www.scopus.com/inward/record.url?scp=0034142382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034142382&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(99)00096-2

DO - 10.1016/S0893-133X(99)00096-2

M3 - Article

VL - 22

SP - 125

EP - 132

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 2

ER -